Clinical trials
Observational Hypertension, Portal trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 21 |
| Recruiting | 8 |
| Completed | 6 |
| Not yet recruiting | 4 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatopancreatobiliary Surgery Institute of Gansu Province | 8 |
| Shanghai Zhongshan Hospital | 8 |
| Nanfang Hospital, Southern Medical University | 4 |
| Northern Jiangsu People's Hospital | 4 |
| Fifth Affiliated Hospital, Sun Yat-Sen University | 2 |
| Qilu Hospital of Shandong University | 2 |
| Renmin Hospital of Wuhan University | 2 |
| Zhongda Hospital | 2 |
| Beijing Friendship Hospital | 1 |
| Changqing Yang | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Portal | 41 |
| Liver Cirrhosis | 15 |
| Fibrosis | 11 |
| Esophageal and Gastric Varices | 5 |
| Hypersplenism | 4 |
| Carcinoma, Hepatocellular | 2 |
| Acute-On-Chronic Liver Failure | 1 |
| Autoimmune Pancreatitis | 1 |
| Colorectal Neoplasms | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.